Stock data
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH) reported revenue of US$719.89M and net income of US$98.09M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$719.89M | US$356.06M | US$140.40M | US$98.09M | — |
| 2024 | US$731.97M | US$373.86M | US$205.42M | US$159.52M | — |
| 2023 | US$644.39M | US$351.12M | US$196.99M | US$137.54M | — |
| 2022 | US$498.99M | US$248.86M | US$107.50M | US$91.39M | — |
| 2021 | US$437.77M | US$199.74M | US$69.89M | US$62.12M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$183.90M | US$30.35M | — |
| 2026-03-31 | US$171.17M | US$6.42M | — |
| 2025-12-31 | US$183.10M | US$24.43M | — |
| 2025-09-30 | US$191.84M | US$17.35M | — |
| 2025-06-30 | US$174.41M | US$31.03M | — |
| 2025-03-31 | US$170.53M | US$25.29M | — |
| 2024-12-31 | US$186.52M | US$37.96M | — |
| 2024-09-30 | US$191.21M | US$40.43M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.